Similar articles

• Studies on orally active cephalosporins. I. Synthesis and structure-activity relationships of new 3-substituted carbamoyloxymethyl cephalosporins.

  Negi S, Yamanaka M, Sugiyama I, Komatsu Y, Sasho M, Tsuruoka A, Kamada A, Tsukada I, Hiruma R, Katsu K, et al. Negi S, et al. J Antibiot (Tokyo). 1994 Dec;47(12):1507-25. doi: 10.7164/antibiotics.47.1507. J Antibiot (Tokyo). 1994. PMID: 7844045
• Studies on orally active cephalosporins. II. Synthesis and structure-activity relations of new [(E) or (Z) 3-substituted carbamoyloxy]-1-propenyl cephalosporins.

  Negi S, Sasho M, Yamanaka M, Sugiyama I, Komatsu Y, Tsuruoka A, Kamada A, Tsukada I, Hiruma R, Katsu K, et al. Negi S, et al. J Antibiot (Tokyo). 1994 Dec;47(12):1526-40. doi: 10.7164/antibiotics.47.1526. J Antibiot (Tokyo). 1994. PMID: 7844046
• Clinical pharmacokinetics of oral cephalosporins.

  Stoeckel K, Hayton WL, Edwards DJ. Stoeckel K, et al. Antibiot Chemother (1971). 1995;47:34-71. doi: 10.1159/000430073. Antibiot Chemother (1971). 1995. PMID: 8554307 Review. No abstract available.
• [A new oral cephem, cefdinir: its structure-activity relationships and biological profile].

  Sakane K, Inamoto Y, Takaya T. Sakane K, et al. Jpn J Antibiot. 1992 Aug;45(8):909-25. Jpn J Antibiot. 1992. PMID: 1433897 Review. Japanese.
• Biological activity of some monocyclic- and bicyclic beta-lactams with specified functional groups.

  Hwu JR, Ethiraj KS, Hakimelahi GH. Hwu JR, et al. Mini Rev Med Chem. 2003 Jun;3(4):305-13. doi: 10.2174/1389557033488132. Mini Rev Med Chem. 2003. PMID: 12678824 Review.